Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06263322 · ClinicalTrials.gov registry record · NA
The ROAMM-EHR Study
A NA study of Peripheral Arterial Disease and Chronic Limb-Threatening Ischemia, sponsored by University of Florida.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06263322: Recruiting NA study of Peripheral Arterial Disease and Chronic Limb-Threatening Ischemia, sponsored by University of Florida.
NCT06263322 is a NA study of Peripheral Arterial Disease and Chronic Limb-Threatening Ischemia that is actively recruiting participants, run by University of Florida. The registered enrollment target is 50 participants, below the 4,206-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06263322, a NA study of Peripheral Arterial Disease and Chronic Limb-Threatening Ischemia, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
In recent years, mobile health (mHealth) apps have promised improved monitoring of health conditions to improve clinical outcomes. The objective of this study is to conduct a pilot randomized clinical trial (RCT) to evaluate the impact of using remotely collected patient generated health data (PGHD) from older patients undergoing bypass surgery due to chronic limb threatening ischemia. The hypothesis is that integrating PGHD with an EHR system will help providers manage post-surgical symptoms and thus improve post-operative mobility and quality of life health outcomes.
Primary Outcome
Patients are asked to complete as much distance as possible over a standardized course
Conditions Studied
Interventions
- BEHAVIORAL Actionable remotely generated health data
- BEHAVIORAL Non-Actionable remotely generated health data
Study Locations (1)
Florida
- Institute of Aging - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-11-16 |
| Est. Completion | 2026-10-17 |
| Phase | NA |
What NCT06263322 shows while recruiting
NCT06263322 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 4,206-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Peripheral Arterial Disease appearing as the primary indexed condition, and to 2 interventions - of which Actionable remotely generated health data is the first listed.
NCT06263322 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06263322 about?
NCT06263322 is a clinical study titled "The ROAMM-EHR Study". In recent years, mobile health (mHealth) apps have promised improved monitoring of health conditions to improve clinical outcomes. The objective of this study is to conduct a pilot randomized clinical trial (RCT) to evaluate the impact of using remotely collected patient generated health data (PGHD)...
What is the current status of trial NCT06263322?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-11-16. Estimated completion is 2026-10-17.
What conditions does trial NCT06263322 study?
This clinical trial studies the following conditions: Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia.
What interventions are being tested in trial NCT06263322?
The interventions under investigation include: Actionable remotely generated health data (BEHAVIORAL), Non-Actionable remotely generated health data (BEHAVIORAL).
Who is sponsoring clinical trial NCT06263322?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06263322 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Arterial Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06263322's enrollment target sits among peer trials
50 52nd of 79 higher than 27 of 79 other Peripheral Arterial Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Peripheral Arterial Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SELUTION4BTK Trial
RECRUITING · NA
-
MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology
RECRUITING · NA
-
Ultrasound Perfusion Estimation for Assessment of Peripheral Arterial Disease
RECRUITING · NA
-
Prehabilitation and Rehabilitation in PAD
RECRUITING · NA
-
Replexa+ Shortwave Diathermy Device for Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy
RECRUITING · NA
-
Assessment of the Utility of the Pantheris Small Vessel (SV) System
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI